Repligen Corp (NASDAQ:RGEN) - Share price


Stock Report

Repligen Corp RGEN

Last Price
$130.97

Day Change
1.76|1.36%

As of 29/05/2020
16:25:56 EDT | USD
Minimum 15 Minutes Delay.

Last Close129.21
Day Range127.40 - 132.66
Mkt Cap6.85Bil
52-Wk Range68.50 - 143.93
Yield %-
ISINUS7599161095
Volume810,595
P/E294.12
P/S23.36
P/CF99.59

Share Price

Financials
201720182019
More ...
Income Statement
Revenue141.24194.03270.25
Operating Income14.0125.9936.08
Net Income28.3516.6221.41
Basic EPS0.740.380.44
Avg. Diluted Shares Outstanding394549
Balance Sheet
Current Assets242.78275.74641.83
Non Current Assets500.74498.88758.29
Total Assets743.52774.621,400.11
Current Liabilities25.21129.8448.31
Total Liabilities151.97159.05340.35
Total Equity591.55615.571,059.77
Cash Flow
Operating Cash Flow17.4532.7767.22
Capital Expenditure-5.45-14.04-23.15
Free Cash Flow12.0018.7344.06

In millions, except "Basic EPS". Currency is USD.

Company Profile

Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

761
Key Stats
More ...
Price/Earning TTM287.13
Price/Book6.32
Price/Sales TTM23.53
Rev Growth (3 year avg)37.24
EPS Growth (3 year avg)-
Operating Margin % TTM13.35
Net Margin % TTM7.92
ROE TTM2.56
Debt/Equity0.25
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.